Immatics (IMTX) Current Deferred Revenue (2019 - 2025)

Immatics (IMTX) reported Current Deferred Revenue of $21.6 million for Q4 2025, down 43.75% on a YoY basis from $38.4 million in Q4 2024, and down 27.78% sequentially from $29.9 million in Q3 2025.

Immatics (IMTX) Current Deferred Revenue (2019 - 2025) Analysis & Trends

Immatics (IMTX) has 7 years of Current Deferred Revenue data on file, last reported at $21.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue fell 43.75% year-over-year to $21.6 million; the trailing twelve-month figure through Dec 2025 stood at $21.6 million (down 43.75% YoY), and the FY2025 full-year result was $20.9 million, down 46.1% from the prior year.
  • Current Deferred Revenue declined to $21.6 million in Q4 2025, from $29.9 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $124.3 million in Q4 2023 to a low of $21.6 million in Q4 2025.
  • A 5-year average of $70.2 million and a median of $71.5 million in 2021 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue jumped 87.56% in 2023 and plunged 70.74% in 2025, its largest moves.
  • Tracing IMTX's Current Deferred Revenue over 5 years: stood at $57.7 million in 2021, then gained by 14.94% to $66.3 million in 2022, then jumped by 87.56% to $124.3 million in 2023, then tumbled by 69.13% to $38.4 million in 2024, then tumbled by 43.75% to $21.6 million in 2025.
  • Business Quant data shows IMTX's Current Deferred Revenue at $21.6 million in Q4 2025, $29.9 million in Q3 2025, and $31.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Immatics 1.14 Bn 1.14 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 21.58 Mn
Sep 30, 2025 29.88 Mn
Jun 30, 2025 31.20 Mn
Mar 31, 2025 30.68 Mn
Dec 31, 2024 38.37 Mn
Sep 30, 2024 75.70 Mn
Jun 30, 2024 102.87 Mn
Mar 31, 2024 104.86 Mn
Dec 31, 2023 124.30 Mn
Sep 30, 2023 67.55 Mn
Jun 30, 2023 74.04 Mn
Mar 31, 2023 70.07 Mn
Dec 31, 2022 66.27 Mn
Sep 30, 2022 104.07 Mn
Jun 30, 2022 123.05 Mn
Mar 31, 2022 47.14 Mn
Dec 31, 2021 57.66 Mn
Sep 30, 2021 72.97 Mn
Jun 30, 2021 74.91 Mn
Mar 31, 2021 86.50 Mn